AAAAAA

   
Results: 1-10 |
Results: 10
PEARLS IN THERAPEUTIC DRUG-MONITORING
Authors: LEADER WG
Citation: Wg. Leader, PEARLS IN THERAPEUTIC DRUG-MONITORING, American journal of health-system pharmacy, 55(19), 1998, pp. 2027-2027
INCOMPATIBILITY BETWEEN CEFTRIAXONE SODIUM AND LABETALOL HYDROCHLORIDE
Authors: LEADER WG JONES JM
Citation: Wg. Leader et Jm. Jones, INCOMPATIBILITY BETWEEN CEFTRIAXONE SODIUM AND LABETALOL HYDROCHLORIDE, American journal of health-system pharmacy, 53(21), 1996, pp. 2639-2639
INTEGRATING PHARMACOKINETICS INTO POINT-OF-CARE INFORMATION-SYSTEMS
Authors: LEADER WG PESTOTNIK SL CHANDLER MHH
Citation: Wg. Leader et al., INTEGRATING PHARMACOKINETICS INTO POINT-OF-CARE INFORMATION-SYSTEMS, Clinical pharmacokinetics, 31(3), 1996, pp. 165-173
PHARMACOKINETIC OPTIMIZATION OF VANCOMYCIN THERAPY
Authors: LEADER WG CHANDLER MHH CASTIGLIA M
Citation: Wg. Leader et al., PHARMACOKINETIC OPTIMIZATION OF VANCOMYCIN THERAPY, Clinical pharmacokinetics, 28(4), 1995, pp. 327-342
SYMPTOMATOLOGY, PULMONARY-FUNCTION AND RESPONSE, AND T-LYMPHOCYTE BETA(2)-RECEPTORS DURING SMOKING CESSATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
Authors: LEADER WG WOLF KM COOPER TM CHANDLER MHH
Citation: Wg. Leader et al., SYMPTOMATOLOGY, PULMONARY-FUNCTION AND RESPONSE, AND T-LYMPHOCYTE BETA(2)-RECEPTORS DURING SMOKING CESSATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE, Pharmacotherapy, 14(2), 1994, pp. 162-172
CREATININE-CLEARANCE ESTIMATES FOR PREDICTING GENTAMICIN PHARMACOKINETIC VALUES IN OBESE PATIENTS
Authors: LEADER WG TSUBAKI T CHANDLER MHH
Citation: Wg. Leader et al., CREATININE-CLEARANCE ESTIMATES FOR PREDICTING GENTAMICIN PHARMACOKINETIC VALUES IN OBESE PATIENTS, American journal of hospital pharmacy, 51(17), 1994, pp. 2125-2130
ESTIMATION OF CREATININE CLEARANCE IN PATIENTS WITH GYNECOLOGIC CANCER
Authors: TSUBAKI T GOODIN S LEADER WG CHANDLER MHH
Citation: T. Tsubaki et al., ESTIMATION OF CREATININE CLEARANCE IN PATIENTS WITH GYNECOLOGIC CANCER, Clinical pharmacy, 12(9), 1993, pp. 685-690
PREDICTING VANCOMYCIN PHARMACOKINETICS BY USING AMINOGLYCOSIDE PHARMACOKINETICS
Authors: WELCH LP LEADER WG CHANDLER MHH
Citation: Lp. Welch et al., PREDICTING VANCOMYCIN PHARMACOKINETICS BY USING AMINOGLYCOSIDE PHARMACOKINETICS, Clinical pharmacy, 12(12), 1993, pp. 909-913
MODIFIED MICHAELIS-MENTEN EQUATION FOR ESTIMATING UNBOUND-PHENYTOIN CONCENTRATIONS
Authors: RHONEY DH LEADER WG CHANDLER MHH
Citation: Dh. Rhoney et al., MODIFIED MICHAELIS-MENTEN EQUATION FOR ESTIMATING UNBOUND-PHENYTOIN CONCENTRATIONS, Clinical pharmacy, 12(12), 1993, pp. 913-917
INFLUENCE OF SERUM SEPARATOR TUBES ON TOTAL AND FREE PHENYTOIN CONCENTRATIONS AND DOSAGES
Authors: CAI WM LEADER WG PORTER WH CHANDLER MHH
Citation: Wm. Cai et al., INFLUENCE OF SERUM SEPARATOR TUBES ON TOTAL AND FREE PHENYTOIN CONCENTRATIONS AND DOSAGES, Therapeutic drug monitoring, 15(5), 1993, pp. 427-430
Risultati: 1-10 |